Target intelligence / Profile preview

Disintegrin and metalloproteinase domain-containing protein 7 (ADAM7)

Target
ADAM7
Molecular classification
Membrane-anchored glycoprotein, Disintegrin and metalloproteinase (ADAM) family (non-catalytic subtype), Cell surface protein, Other (ADAM proteins, but ADAM7 is non-enzymatic)
01

Overview

Disintegrin and metalloproteinase domain-containing protein 7 (ADAM7) is a membrane-anchored protein in the ADAM family, structurally related to snake venom disintegrins but, unlike many ADAMs, lacking proteolytic activity[1][5]. ADAM7 is predominantly expressed in the epididymis and sperm, where it functions in sperm maturation, cell–cell adhesion, and possibly sperm–egg fusion[1][4][5]. The protein is transferred from epididymal epithelial cells onto the sperm membrane, modulating protein complexes important for the maturation of sperm and sperm capacitation[1]. While ADAM7 has been linked to disease states (such as melanoma and primary biliary cirrhosis), it is not considered a therapeutic target due to its lack of enzymatic activity or established druggability[5]. It primarily plays a specialized physiological role in male reproductive biology and has limited disease or pharmacological relevance outside specific contexts.

Other names
ADAM7ADAM-7EAPIGP-83GP83disintegrin and metalloproteinase domain-containing protein 7epididymal apical protein Isperm maturation-related glycoprotein GP-83
02

Biological functions

Sperm maturationCell adhesionProtein–protein interactionsSperm–egg fusionMaintenance of epithelial cell morphology in the epididymis
03

Disease associations

Cancer (notably melanoma, possibly others)Other (Primary biliary cirrhosis, type 4)
04

Safety considerations

Unclear therapeutic relevance due to lack of enzymatic activityNot currently a druggable target

Beyond the preview

Go deeper on Disintegrin and metalloproteinase domain-containing protein 7 (ADAM7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Disintegrin and metalloproteinase domain-containing protein 7 (ADAM7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call